| 期刊論文| 1. | Le, Tung Thanh、Andreadakis, Zacharias、Kumar, Arun、Román, Raúl Gómez、Tollefsen, Stig、Saville, Melanie、Mayhew, Stephen(20200409)。The COVID-19 vaccine development landscape。Nature Reviews Drug Discovery，19，305-306。   | | 2. | Logunov, Denis Y.、Dolzhikova, Inna V.、Shcheblyakov, Dmitry V.、Tukhvatulin, Amir I.、Zubkova, Olga V.、Dzharullaeva, Alina S.、Kovyrshina, Anna V.、Lubenets, Nadezhda L.、Grousova, Daria M.、Erokhova, Alina S.、Botikov, Andrei G.、Izhaeva, Fatima M.、Popova, Olga、Ozharovskaya, Tatiana A.、Esmagambetov, Ilias B.、Favorskaya, Irina A.、Zrelkin, Denis I.、Voronina, Daria V.、Shcherbinin, Dmitry N.、Semikhin, Alexander S.、Simakova, Yana V.、Tokarskaya, Elizaveta A.、Egorova, Daria A.、Shmarov, Maksim M.、Nikitenko, Natalia A.、Gushchin, Vladimir A.、Smolyarchuk, Elena A.、Zyryanov, Sergey K.、Borisevich, Sergei V.、Naroditsky, Boris S.、Gintsburg, Alexander L.、Gam-COVID-Vac Vaccine Trial Group(2021)。Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia。The Lancet，397(10275)，671-681。 | | 3. | Wiersinga, W. Joost、Rhodes, Andrew、Cheng, Allen C.、Peacock, Sharon J.、Prescott, Hallie C.(2020)。Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review。The Journal of the American Medical Association，324(8)，782-793。 | | 4. | Zhang, Liangsheng、Shen, Fu-Ming、Chen, Fei、Lin, Zhenguo(20200801)。Origin and Evolution of the 2019 Novel Coronavirus。Clinical Infectious Diseases，71(15)，882-883。 | | 5. | Zhang, Yuhao、Geng, Xiuchao、Tan, Yanli、Li, Qiang、Xu, Can、Xu, Jianglong、Hao, Liangchao、Zeng, Zhaomu、Luo, Xianpu、Liu, Fulin、Wang, Hong(2020)。New understanding of the damage of SARS-CoV-2 infection outside the respiratory system。Biomedicine & Pharmacotherapy，127，(110195)1-(110195)7。 | | 6. | Li, Hao、Xue, Qun、Xu, Xingshun(20200513)。Involvement of the Nervous System in SARS-CoV-2 Infection。Neurotoxicity Research，38(1)，1-7。 | | 7. | Khuroo, Mohammad S.、Khuroo, Mohammad、Khuroo, Mehnaaz S.、Sofi, Ahmad A.、Khuroo, Naira S.(2020)。COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!。Journal of Clinical and Experimental Hepatology，10(6)，610-621。 | | 8. | Zhang, Zhe、Zhou, Li、Xie, Na、Nice, Edouard C.、Zhang, Tao、Cui, Yongping、Huang, Canhua(2020)。Overcoming cancer therapeutic bottleneck by drug repurposing。Signal Transduction and Targeted Therapy，5，(113)1-(113)25。 | | 9. | Lurie, Nicole、Saville, Melanie、Hatchett, Richard、Halton, Jane(20200521)。Developing Covid-19 Vaccines at Pandemic Speed。New England Journal of Medicine，382(21)，1969-1973。 | | 10. | Thomson, Kyle、Nachlis, Herschel(20200831)。Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval。The Journal of the American Medical Association，324(13)，1282-1283。 | | 11. | Mathew, Shilu、Faheem, Muhammed、Hassain, Neeraja A.、Benslimane, Fatiha M.、Thani, Asmaa A. Al、Zaraket, Hassan、Yassine, Hadi M.(2021)。Platforms Exploited for SARS-CoV-2 Vaccine Development。Vaccines，9(1)，(11)1-(11)24。 | | 12. | Altmann, Daniel M.、Boyton, Rosemary J.、Beale, Rupert(20210312)。Immunity to SARS-CoV-2 variants of concern。Science，371(6534)，1103-1104。 | | 13. | Goepfert, Paul A.、Fu, Bo、Chabanon, Anne-Laure、Bonaparte, Matthew I.、Davis, Matthew G.、Essink, Brandon J.、Frank, Ian、Haney, Owen、Janosczyk, Helene、Keefer, Michael C.、Koutsoukos, Marguerite、Kimmel, Murray A.、Masotti, Roger、Savarino, Stephen J.、Schuerman, Lode、Schwartz, Howard、Sher, Lawrence D.、Smith, Jon、Tavares-Da-Silva, Fernanda、Gurunathan, Sanjay、DiazGranados, Carlos A.、De Bruyn, Guy(2021)。Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study。The Lancet Infectious Diseases，21(9)，1257-1270。 | | 14. | Doerfler, Walter(2021)。Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?。Virus Research，302，(198466)1-(198466)7。 | | 15. | Baldo, Aline、Leunda, Amaya、Willemarck, Nicolas、Pauwels, Katia(20210503)。Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2。Vaccines，9(5)，(453)1-(453)20。 | | 16. | Meng, Fan-Yue、Gao, Fan、Jia, Si-Yue、Wu, Xiang-Hong、Li, Jing-Xin、Guo, Xi-Ling、Zhang, Jia-Lu、Cui, Bo-Pei、Wu, Zhi-Ming、Wei, Ming-Wei、Ma, Zhi-Long、Peng, Hai-Lin、Pan, Hong-Xing、Fan, Lin、Zhang, Jing、Wan, Jiu-Qin、Zhu, Zhong-Kui、Wang, Xue-Wen、Zhu, Feng-Cai(20210715)。Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials。Signal Transduction and Targeted Therapy，6，(271)1-(271)11。 | | 17. | Sadoff, Jerald、Le Gars, Mathieu、Shukarev, Georgi、Heerwegh, Dirk、Truyers, Carla、De Groot, Anne M.、Stoop, Jeroen、Tete, Sarah、Van Damme, Wim、Leroux-Roels, Isabel、Berghmans, Pieter-Jan、Kimmel, Murray、Van Damme, Pierre、De Hoon, Jan、Smith, William、Stephenson, Kathryn E.、De Rosa, Stephen C.、Cohen, Kristen W.、McElrath, Juliana、Cormier, Emmanuel、Scheper, Gert、Barouch, Dan H.、Hendriks, Jenny、Struyf, Frank、Douoguih, Macaya、Van Hoof, Johan、Schuitemaker, Hanneke(20210513)。Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine。New England Journal of Medicine，384，1824-1835。 | | 18. | Baden, Lindsey R.、Sahly, Hana M. El、Essink, Brandon、Kotloff, Karen、Frey, Sharon、Novak, Rick、Diemert, David、Spector, Stephen A.、Rouphael, Nadine、Creech, C. Buddy、McGettigan, John、Khetan, Shishir、Segall, Nathan、Solis, Joel、Brosz, Adam、Fierro, Carlos、Schwartz, Howard、Neuzil, Kathleen、Corey, Lawrence、Gilbert, Peter、Janes, Holly、Follmann, Dean、Marovich, Mary、Mascola, John、Polakowski, Laura、Ledgerwood, Julie、Graham, Barney S.、Bennett, Hamilton、Pajon, Rolando、Knightly, Conor、Leav, Brett、Deng, Weiping、Zhou, Honghong、Han, Shu、Ivarsson, Melanie、Miller, Jacqueline、Zaks, Tal、COVE Study Group(2021)。Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine。New England Journal of Medicine，384(5)，403-416。 | | 19. | Herishanu, Yair、Avivi, Irit、Aharon, Anat、Shefer, Gabi、Levi, Shai、Bronstein, Yotam、Morales, Miguel、Ziv, Tomer、Arbel, Yamit Shorer、Scarfò, Lydia、Joffe, Erel、Perry, Chava、Ghia, Paolo(20210610)。Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia。Blood, The Journal of the American Society of Hematology，137(23)，3165-3173。 | | 20. | Frater, John、Ewer, Katie J.、Ogbe, Ane、Pace, Mathew、Adele, Sandra、Adland, Emily、Alagaratnam, Jasmini、Aley, Parvinder K.、Ali, Mohammad、Ansari, M. Azim、Bara, Anna、Bittaye, Mustapha、Broadhead, Samantha、Brown, Anthony、Brown, Helen、Cappuccini, Federica、Cooney, Enya、Dejnirattisai, Wanwisa、Dold, Christina、Fairhead, Cassandra、Fok, Henry、Folegatti, Pedro M.、Fowler, Jamie、Gibbs, Charlotte、Goodman, Anna L.、Jenkin, Daniel、Jones, Mathew、Makinson, Rebecca、Marchevsky, Natalie G.、Mujadidi, Yama F.、Nguyen, Hanna、Parolini, Lucia、Petersen, Claire、Plested, Emma、Pollock, Katrina M.、Ramasamy, Maheshi N.、Rhead, Sarah、Robinson, Hannah、Robinson, Nicola、Rongkard, Patpong、Ryan, Fiona、Serrano, Sonia、Tipoe, Timothy、Voysey, Merryn、Waters, Anele、Zacharopoulou, Panagiota、Barnes, Eleanor、Dunachie, Susanna、Goulder, Philip、Klenerman, Paul、Screaton, Gavin R.、Winston, Alan、Hill, Adrian V. S.、Gilbert, Sarah C.、Pollard, Andrew J.、Fidler, Sarah、Fox, Julie、Lambe, Teresa(2021)。Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial。The Lancet HIV，8(8)，e474-e485。 | | 21. | Hsieh, Szu-Min、Liu, Wang-Da、Huang, Yu-Shan、Lin, Yi‑Jiun、Hsieh, Erh-Fang、Lian, Wei-Cheng、Chen, Charles、Janssen, Robert、Tai, I-Chen、Chang, Shan-Chwen(2021)。Safety and Immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted With CpG 1018 and Aluminum Hydroxide in Healthy Adults: A Phase 1, Dose-Escalation Study。EClinicalMedicine，38，(100989)1-(100989)8。 | | 22. | Korokhov, Nikolay、Noureddini, Sam C.、Curiel, David T.、Santegoets, Saskia J. A. M.、Scheper, Rik J.、De Gruijl, Tanja D.(2005)。A Single-Component CD40-Targeted Adenovirus Vector Displays Highly Efficient Transduction and Activation of Dendritic Cells in a Human Skin Substrate System。Molecular Pharmaceutics，2(3)，218-223。 | | 23. | Abe, Shinya、Okuda, Kenji、Ura, Takehiro、Kondo, Asami、Yoshida, Atsushi、Yoshizaki, Shinji、Mizuguchi, Hiroyuki、Klinman, Dennis、Shimada, Masaru(2009)。Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5。The Journal of Gene Medicine: A cross-disciplinary journal of research on the science of gene transfer and its clinical applications，11(7)，570-579。 | | 24. | King, R. Glenn、Silva-Sanchez, Aaron、Peel, Jessica N.、Botta, Davide、Dickson, Alexandria M.、Pinto, Amelia K.、Meza-Perez, Selene、Allie, S. Rameeza、Schultz, Michael D.、Liu, Mingyong、Bradley, John E.、Qiu, Shihong、Yang, Guang、Zhou, Fen、Zumaquero, Esther、Simpler, Thomas S.、Mousseau, Betty、Killian, John T. Jr.、Dean, Brittany、Shang, Qiao、Tipper, Jennifer L.、Risley, Christopher A.、Harrod, Kevin S.、Feng, Tsungwei、Lee, Young、Shiberu, Bethlehem、Krishnan, Vyjayanthi、Peguillet, Isabelle、Zhang, Jianfeng、Green, Todd J.、Randall, Troy D.、Suschak, John J.、Georges, Bertrand、Brien, James D.、Lund, Frances E.、Roberts, M. Scot(20210809)。Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge。Vaccines，9(8)，(881)1-(881)21。 | | 25. | Yusuf, Helmy、Kettb, Vicky(2017)。Current prospects and future challenges for nasal vaccine delivery。Human Vaccines & Immunotherapeutics，13(1)，34-45。 | | 26. | Khurana, Amit、Allawadhi, Prince、Khurana, Isha、Allwadhi, Sachin、Weiskirchen, Ralf、Banothu, Anil Kumar、Chhabra, Deepak、Joshi, Kamaldeep、Bharani, Kala Kumar(2021)。Role of nanotechnology behind the success of mRNA vaccines for COVID-19。Nano Today，38，(101142)1-(101142)6。 | | 27. | Reichmuth, Andreas M.、Oberli, Matthias A.、Jaklenec, Ana、Langer, Robert、Blankschtein, Daniel(2016)。mRNA vaccine delivery using lipid nanoparticles。Therapeutic Delivery，7(5)，319-334。 | 單篇論文| 1. | Naughton, Colleen C.，Roman, Fernando A. Jr.，Alvarado, Ana Grace F.，Tariqi, Arianna Q.，Deeming, Matthew A.，Kadonsky, Krystin F.，Bibby, Kyle，Bivins, Aaron，Medema, Gertjan，Ahmed, Warish，Katsivelis, Panagis，Allan, Vajra，Sinclair, Ryan，Rose, Joan B.(2021)。Show us the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps，https://doi.org/10.1101/2021.03.14.21253564。 | | 2. | Lien, Chia-En，Kuo, Tsun-Yung，Lin, Yi-Jiun，Lian, Wei-Cheng，Lin, Meei-Yun，Liu, Luke Tzu-Chi，Chou, Yu-Chi，Chen, Charles(20210322)。Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern，https://doi.org/10.1101/2021.03.19.21254000。 | |